Abstract
Introduction Ground-based walking is a simple training modality which would suit pulmonary rehabilitation (PR) settings with limited access to specialist equipment. Patients with advanced COPD are, however, unable to walk uninterruptedly at a relatively fast walking pace to optimise training benefits.
Objective To compare walking distance and circulatory responses between an intermittent (IntSWT) and an endurance shuttle walking (ESWT) protocol.
Methods In this cross-sectional study we measured in 14 COPD patients (mean±SD FEV1: 45±21% predicted), walking distance, cardiac output (CO), heart rate (HR), arterial oxygen saturation (SpO2), and symptoms during (a) IntSWT, consisting of 1-min walking alternating with 1-min rest, and (b) ESWT, both sustained at 85% of peak VO2 predicted to the limit of tolerance (Tlim).
Results Median (IQR) distance and endurance time were greater (p=0.001) during IntSWT [735 (375–1107) m and 19.61 (19.0–28.8) min, respectively] compared to ESWT [190 (117–360) m and 3.23 (2.32–5.75) min, respectively]. At iso-distance (distance at Tlim during ESWT) IntSWT compared to ESWT was associated with lower CO (8.6±2.6 versus 10.3±3.7 L/min; p=0.013), HR (96±14 versus 103±13 beats/min; p=0.001), greater SpO2 (92±6 versus 90±7 %; p=0.002), and lower symptoms of dyspnoea (2.8±1.3 versus 4.9±1.4; p=0.001) and leg discomfort (2.3±1.7 versus 4.2±2.2; p=0.001). Furthermore, throughout the walking tests, IntSWT compared to ESWT was associated with lower symptoms of dyspnoea (p=0.001), and leg discomfort (p=0.03) (figure 1). However, at Tlim symptoms of dyspnoea and leg discomfort were not different between IntSWT and ESWT, suggesting that the major reasons for limiting walking endurance in both modalities were having reached comparable intensity of symptoms, which took longer during IntSWT compared to ESWT.
Objective To compare walking distance and circulatory responses between an intermittent (IntSWT) and an endurance shuttle walking (ESWT) protocol.
Methods In this cross-sectional study we measured in 14 COPD patients (mean±SD FEV1: 45±21% predicted), walking distance, cardiac output (CO), heart rate (HR), arterial oxygen saturation (SpO2), and symptoms during (a) IntSWT, consisting of 1-min walking alternating with 1-min rest, and (b) ESWT, both sustained at 85% of peak VO2 predicted to the limit of tolerance (Tlim).
Results Median (IQR) distance and endurance time were greater (p=0.001) during IntSWT [735 (375–1107) m and 19.61 (19.0–28.8) min, respectively] compared to ESWT [190 (117–360) m and 3.23 (2.32–5.75) min, respectively]. At iso-distance (distance at Tlim during ESWT) IntSWT compared to ESWT was associated with lower CO (8.6±2.6 versus 10.3±3.7 L/min; p=0.013), HR (96±14 versus 103±13 beats/min; p=0.001), greater SpO2 (92±6 versus 90±7 %; p=0.002), and lower symptoms of dyspnoea (2.8±1.3 versus 4.9±1.4; p=0.001) and leg discomfort (2.3±1.7 versus 4.2±2.2; p=0.001). Furthermore, throughout the walking tests, IntSWT compared to ESWT was associated with lower symptoms of dyspnoea (p=0.001), and leg discomfort (p=0.03) (figure 1). However, at Tlim symptoms of dyspnoea and leg discomfort were not different between IntSWT and ESWT, suggesting that the major reasons for limiting walking endurance in both modalities were having reached comparable intensity of symptoms, which took longer during IntSWT compared to ESWT.
| Original language | English |
|---|---|
| Pages (from-to) | A53-A54 |
| Number of pages | 2 |
| Journal | Thorax |
| Volume | 77 |
| Issue number | Suppl 1 |
| Early online date | 11 Nov 2022 |
| DOIs | |
| Publication status | Published - 7 Jul 2023 |
| Event | British Thoracic Society Winter Meeting 2022 - QEII Centre, London, United Kingdom Duration: 23 Nov 2022 → 25 Nov 2022 |